Hi, I'm new to posting here but have been following this group for awhile and find it to be a very helpful and supportive community. I have a question about a research study published March 26, 2024, in a journal called Cell Reports (I did a quick search and learned that Cell Reports is a legitimate and reputable journal). I'm not sure how I found the study. I am not a scientist or medical professional.
In the ten years since I was diagnosed with PD, I have been under instruction from the medical community to supplement with B12 - the more the better. As I understand this study, it suggests that B12 may actually worsen PD symptoms. Does anyone know anything about this or can comment on this study?
Link is here: cell.com/cell-reports/fullt...
And here is the explanation of the study's conclusions after I ran the study through Scholarcy:
"Conclusions
The study concludes that propionate is a key metabolite that modulates neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease through bidirectional regulation between the intestine and neurons.
The study concludes that vitamin B12 and α-synuclein aggregation contribute to neurodegeneration through similar metabolic changes and transcriptional reprogramming, and that restoring propionate levels may be a potential therapeutic strategy for Parkinson's disease.
The study concludes that SCFAs, particularly propionate, are promising candidates for the metabolic rescue of Parkinson's disease, and that vitamin B12 has a detrimental effect on neurodegeneration in C. elegans models of Parkinson's disease.
The study concludes that vitamin B12 promotes neurodegeneration in C. elegans models of Parkinson's disease, and that depletion of dietary vitamin B12 may be a potential therapeutic strategy for the treatment of Parkinson's disease.
The study concludes that vitamin B12 does not alter neuronal a-syn aggregation, but its effects on neurodegeneration are downstream of protein aggregation. The study also suggests that propionate may be a potential therapeutic target for neurodegenerative diseases.
The study concludes that propionate has a neuroprotective effect against a-syn-induced neurodegeneration in C. elegans and mammalian neurons, and that this effect is mediated by the activation of metabolic genes in the intestine and the improvement of mitochondrial functions."